{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:56:08Z","timestamp":1776329768951,"version":"3.50.1"},"reference-count":37,"publisher":"Baskent University","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.6002\/ect.2020.0495","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T07:40:57Z","timestamp":1620114057000},"page":"62-68","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Role of Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Prognosis of Hepatocellular Carcinoma in a Murine Model"],"prefix":"10.6002","volume":"20","author":[{"given":"Wafaa","family":"Mansour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Elzayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimaa","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa","family":"Abd El Fattah El Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taghreed","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Saber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589-604. doi:10.1038\/s41575-019-0186-y","DOI":"10.1038\/s41575-019-0186-y"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Abdel Aziz M, Atta H, Roshdy N, et al. Amelioration of murine schistosoma mansoni induced liver fibrosis by mesenchymal stem cells. J Stem Cells Regen Med. 2012;8(1):28-34. doi: 10.46582\/jsrm.0801005","DOI":"10.46582\/jsrm.0801005"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst. 2020;32(1):5. doi:10.1186\/s43046-020-0016-x","DOI":"10.1186\/s43046-020-0016-x"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282-5294. doi:10.3748\/wjg.v23.i29.5282","DOI":"10.3748\/wjg.v23.i29.5282"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Li GC, Ye QH, Dong QZ, Ren N, Jia HL, Qin LX. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models. Oncol Rep. 2013;29(2):713-719. doi:10.3892\/or.2012.2174","DOI":"10.3892\/or.2012.2174"},{"key":"ref5","unstructured":"6. Abdalla E, Stuart KE. Overview of treatment approaches for hepatocellular carcinoma. Exp Tox Pathol. 2019;66:429-436."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Kwon SG, Kwon YW, Lee TW, Park GT, Kim JH. Recent advances in stem cell therapeutics and tissue engineering strategies. Biomater Res. 2018;22:36. doi:10.1186\/s40824-018-0148-4","DOI":"10.1186\/s40824-018-0148-4"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol. 2004;32(5):414-425. doi:10.1016\/j.exphem.2004.02.004","DOI":"10.1016\/j.exphem.2004.02.004"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9. El Baz H, Demerdash Z, Kamel M, et al. Transplant of hepatocytes, undifferentiated mesenchymal stem cells, and in vitro hepatocyte-differentiated mesenchymal stem cells in a chronic liver failure experimental model: a comparative study. Exp Clin Transplant. 2018;16(1):81-89. doi:10.6002\/ect.2016.0226","DOI":"10.6002\/ect.2016.0226"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Crippa S, Santi L, Bosotti R, Porro G, Bernardo ME. Bone marrow-derived mesenchymal stromal cells: a novel target to optimize hematopoietic stem cell transplantation protocols in hematological malignancies and rare genetic disorders. J Clin Med. 2019;9(1):2. doi:10.3390\/jcm9010002","DOI":"10.3390\/jcm9010002"},{"key":"ref10","unstructured":"11. Fagioli F, Berger M, Brach del Prever A, et al. Regression of metastatic osteosarcoma following non-myeloablative stem cell transplantation. A case report. Haematologica. 2003;88(5):ECR16"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Ringden O, Le Blanc K. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS. 2005;113(11-12):813-830. doi:10.1111\/j.1600-0463.2005.apm_336.x","DOI":"10.1111\/j.1600-0463.2005.apm_336.x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Omuro Y, Matsumoto G, Sasaki T, et al. Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. Bone Marrow Transplant. 2003;31(10):943-945. doi:10.1038\/sj.bmt.1703932","DOI":"10.1038\/sj.bmt.1703932"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Liu J, Shi Y, Han J, Zhang Y, Cao Z, Cheng J. Quantitative tracking tumor suppression efficiency of human umbilical cord-derived mesenchymal stem cells by bioluminescence imaging in mice hepatoma model. Int J Stem Cells. 2020;13(1):104-115. doi:10.15283\/ijsc19098","DOI":"10.15283\/ijsc19098"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Bhat V, Allan AL, Raouf A. Role of the microenvironment in regulating normal and cancer stem cell activity: implications for breast cancer progression and therapy response. Cancers (Basel). 2019;11(9):1240. doi:10.3390\/cancers11091240","DOI":"10.3390\/cancers11091240"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Moharib MN, Waldemar, Olszewski L, et al. Allogenic hepatocyte transplantation in immunomodulated Lewis rats with acute liver insufficiency following hepatectomy. J Egypt Soc Parasitol. 2014;44(1):221-228. doi:10.12816\/0006462","DOI":"10.12816\/0006462"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301-1314. doi:10.1016\/S0140-6736(18)30010-2","DOI":"10.1016\/S0140-6736(18)30010-2"},{"key":"ref17","unstructured":"18. Tunissiolli NM, Castanhole-Nunes MMU, Biselli-Chicote PM, et al. Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pac J Cancer Prev. 2017;18(4):863-872. doi:10.22034\/APJCP.2017.18.4.863"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393-403. doi:10.1111\/j.1365-2184.1970.tb00347.x","DOI":"10.1111\/j.1365-2184.1970.tb00347.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-395. doi:10.1080\/14653240500319234","DOI":"10.1080\/14653240500319234"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Yin Z, Jiang K, Li R, Dong C, Wang L. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy. Mol Cancer. 2018;17(1):178. doi:10.1186\/s12943-018-0926-6","DOI":"10.1186\/s12943-018-0926-6"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Jekarl DW, Lee S, Kwon JH, et al. Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma. PLoS One. 2019;14(11):e0224318. doi:10.1371\/journal.pone.0224318","DOI":"10.1371\/journal.pone.0224318"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Liu C, Li L, Lu WS, et al. A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization. BMC Cancer. 2018;18(1):216. doi:10.1186\/s12885-018-4121-3","DOI":"10.1186\/s12885-018-4121-3"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102(10):3837-3844. doi:10.1182\/blood-2003-04-1193","DOI":"10.1182\/blood-2003-04-1193"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Zhang LJ, Wang XZ. Interleukin-10 and chronic liver disease. World J Gastroenterol. 2006;12(11):1681-1685. doi:10.3748\/wjg.v12.i11.1681","DOI":"10.3748\/wjg.v12.i11.1681"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Dokka S, Shi X, Leonard S, Wang L, Castranova V, Rojanasakul Y. Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol Lung Cell Mol Physiol. 2001;280(6):L1196-1202. doi:10.1152\/ajplung.2001.280.6.L1196","DOI":"10.1152\/ajplung.2001.280.6.L1196"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Liu Y, Yin Z, Zhang R, et al. MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6. Biochem Biophys Res Commun. 2014;450(4):1409-1415. doi:10.1016\/j.bbrc.2014.07.001","DOI":"10.1016\/j.bbrc.2014.07.001"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Bernardo ME, Ball LM, Cometa AM, et al. Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant. 2011;46(2):200-207. doi:10.1038\/bmt.2010.87","DOI":"10.1038\/bmt.2010.87"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Grivennikov SI, Karin M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis. 2011;70 Suppl 1:i104-108. doi:10.1136\/ard.2010.140145","DOI":"10.1136\/ard.2010.140145"},{"key":"ref29","unstructured":"30. Sun J, Liao K, Wang Y, Zhang L. Interferon-gamma polymorphism and hepatocellular carcinoma susceptibility: a meta analysis. Int J Clin Exp Med. 2015;8(4):5667-5674."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Attallah AM, El-Far M, Zahran F, et al. Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma. J Immunoassay Immunochem. 2016;37(6):597-610. doi:10.1080\/15321819.2016.1179646","DOI":"10.1080\/15321819.2016.1179646"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Li N, Wang J, Zhang N, et al. Cross-talk between TNF-alpha and IFN-gamma signaling in induction of B7-H1 expression in hepatocellular carcinoma cells. Cancer Immunol Immunother. 2018;67(2):271-283. doi:10.1007\/s00262-017-2086-8","DOI":"10.1007\/s00262-017-2086-8"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Calderaro J, Rousseau B, Amaddeo G, et al. Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features. Hepatology. 2016;64(6):2038-2046. doi:10.1002\/hep.28710","DOI":"10.1002\/hep.28710"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Abdel Aziz MT, El Asmar MF, Atta HM, et al. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. J Exp Clin Cancer Res. 2011;30(1):49. doi:10.1186\/1756-9966-30-49","DOI":"10.1186\/1756-9966-30-49"},{"key":"ref34","unstructured":"35. Saad El-Din S, Fouad H, Rashed LA, Mahfouz S, Hussein RE. Impact of mesenchymal stem cells and vitamin d on transforming growth factor beta signaling pathway in hepatocellular carcinoma in rats. Asian Pac J Cancer Prev. 2018;19(4):905-912. doi:10.22034\/APJCP.2018.19.4.905"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Meier RP, Mahou R, Morel P, et al. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol. 2015;62(3):634-641. doi:10.1016\/j.jhep.2014.10.030","DOI":"10.1016\/j.jhep.2014.10.030"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol. 2005;16(12):3527-3534. doi:10.1681\/ASN.2005050544","DOI":"10.1681\/ASN.2005050544"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T03:03:20Z","timestamp":1642993400000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/1\/0\/62\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2020.0495","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}